SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-22-005825
Filing Date
2022-05-27
Accepted
2022-05-27 17:00:32
Documents
1
Period of Report
2022-05-26

Document Format Files

Seq Description Document Type Size
1 form4-05272022_050501.html 4  
1 form4-05272022_050501.xml 4 3935
  Complete submission text file 0001415889-22-005825.txt   5315
Mailing Address 100 BINNEY STREET STE 600 CAMBRIDGE MA 02142
Business Address 100 BINNEY STREET STE 600 CAMBRIDGE MA 02142 617-336-7540
Sigilon Therapeutics, Inc. (Issuer) CIK: 0001821323 (see all company filings)

IRS No.: 474005543 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address C/O SIGILON THERAPEUTICS, INC. 100 BINNEY STREET, SUITE 600 CAMBRIDGE MA 02142
Business Address
Story Brooke (Reporting) CIK: 0001866136 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39746 | Film No.: 22978671